Darbepoetin alfa is safe and effective for the treatment of renal anemia in diabetic and elderly dialysis patients.

被引：0
|
作者：
Martinez-Castelao, A [1 ]
Bestard, O [1 ]
机构：
[1] Bellvitge Hosp, Serv Nefrol Feixa Llarga, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：603A / 603A
页数：1
相关论文
共 50 条
  • [31] Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan
    Motoshi Hattori
    Akira Matsunaga
    Yuko Akioka
    Shuichiro Fujinaga
    Takuhito Nagai
    Osamu Uemura
    Hyogo Nakakura
    Akira Ashida
    Koichi Kamei
    Shuichi Ito
    Takuji Yamada
    Yoshimitsu Goto
    Toshiyuki Ohta
    Masataka Hisano
    Yasuhiro Komatsu
    Noritomo Itami
    Clinical and Experimental Nephrology, 2013, 17 : 582 - 588
  • [32] Comment: Epoetin alfa versus darbepoetin alfa for cancer patients with treatment-related anemia
    Yang, MC
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (05) : 998 - 999
  • [33] Comparison of anemia treatment outcomes in patients with cancer receiving epoetin alfa and darbepoetin alfa.
    Fahrbach, KR
    Frame, D
    Scheye, R
    Fastenau, JM
    Drielick, M
    Piech, CT
    Nalysnyk, L
    BLOOD, 2003, 102 (11) : 510B - 511B
  • [34] Once weekly erythropoietin omega is safe and effective in treatment of anemia in dialysis patients
    Milutinovic, S
    Plavljanic, D
    Orsanic, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 463A - 463A
  • [35] Epoetin alfa and darbepoetin alfa anemia treatment outcomes in cancer patients from a VA perspective
    Papatheofanis, FJ
    Fastenau, JM
    Chiang, T
    Piech, CT
    VALUE IN HEALTH, 2004, 7 (03) : 246 - 246
  • [36] DARBEPOETIN ALFA ONCE IN 4 WEEKS CORRECTS ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
    Park, Mooyong
    Choi, Soo Jeong
    Kim, Jin Kuk
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1183 - I1184
  • [37] Darbepoetin alfa once every 2 weeks for treatment of anemia in dialysis patients:: a combined analysis of eight multicenter trials
    Mann, J.
    Kessler, M.
    Villa, G.
    Martinez-Castelao, A.
    Feldt-Rasmussen, B.
    Cruz, J.
    Hoerl, W. H.
    Mattin, C.
    Praml, C.
    Wilkie, M.
    CLINICAL NEPHROLOGY, 2007, 67 (03) : 140 - 148
  • [38] Evaluating Darbepoetin Alfa Dosing Strategies in Renal Transplant Anemia
    Courson, A.
    Nesselhauf, N.
    Fester, K.
    McDermott, J.
    Scheffert, J.
    Lee, J.
    Anamisis, A.
    Tsapepas, D.
    TRANSPLANTATION, 2014, 98 : 815 - 815
  • [39] Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
    Swedberg, Karl
    Young, James B.
    Anand, Inder S.
    Cheng, Sunfa
    Desai, Akshay S.
    Diaz, Rafael
    Maggioni, Aldo P.
    McMurray, John J. V.
    O'Connor, Christopher
    Pfeffer, Marc A.
    Solomon, Scott D.
    Sun, Yan
    Tendera, Michal
    van Veldhuisen, Dirk J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1210 - 1219
  • [40] Extended dosing of darbepoetin alfa in peritoneal dialysis patients
    Mariano Feriani
    Johan MJ De Meester
    Lawrence P McMahon
    Jacques B Rottembourg
    Ian Bridges
    Mourad Farouk
    Wolfgang Pronai
    BMC Nephrology, 12
12345